Will Boston Scientific Corporation (NYSE: BSX) even manage to turn in the expected 1/3 cut in per-share earnings when it announces its Q4-2009 results after the market closes on Wednesday, February 10th? Analysts are expecting to see income of $0.13 per share - much less than the $0.21 per share earned for the same quarter a year earlier.

If the company does indeed clear $0.13 per share, it will have earned $0.50 per share for the whole year. That's two cents less than 2008's per-share earnings. For 2010, analysts expect Boston Scientific Corporation to earn $0.52 per share.

Q4 2009 revenue is anticipated to have moved from $2.0 billion to $2.08 billion. At that level, full-year revenue will have risen from $8.05 billion to $8.18 billion.

Boston Scientific met earnings expectations in three of its last four quarters, falling short by two cents per share in the most recent one.

Stocks In Focus For Wednesday

Among the companies whose shares are expected to see active trade in Wednesday’s session are Allstate, Activision Blizzard, and Prudential.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5323944 for the full story.

Boston Scientific (NYSE: BSX) opened at $8.22. So far today, the stock has hit a low of $8.08 and a high of $8.24. BSX is now trading at $8.18, up $0.03 (0.38%). The stock hit its 52-Week high...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

New York, Feb 10th (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) are trading very close to calculated support at $8.06 with current price action closing at just $8.23 places the stock price near levels where traders will start paying attention.

Boston Scientific Corporation (NYSE:BSX) develops, manufactures, an. Read More --

New York, Feb 9th (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) are trading flat by 0.00% ahead of its quarterly earnings release. Boston Scientific, is expected to release its quarterly results on February 10th.

Wall Street Analysts consensus calls for a profit of $0.13 a share on. Read More --

Boston Scientific Corporation is scheduled to report December 2009 quarter (Q4 2009) results on Wednesday, February 10, 2010. In the last four quarters ending September 2009, the company disappointed investors with below analysts’ consensus estimates.[More...]

American Medical Systems Holdings, Inc. (AMMD) recently entered into a new agreement with Tissue Genesis, Inc., an emerging leader in advanced tissue engineering and cell therapy solutions, for the research and development of adipose (fat) derived regenerative cells for use in treating pelvic health disorders. Per the agreement, American Medical has a four year option to [...]

(AMMD) American Medical Systems Holdings Earns New Agreement

The global medical devices industry is fairly large, with annual worldwide sales in excess of $200 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices, Healthcare IT, etc. We recommend companies providing life-sustaining products to investors in the medical devices [...]

(MDRX) Medical Devices Stock Review – Feburary 2010 – Industry Outlook

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Schaeffer's Laura Houser takes a look at activity on the Street after the market close

Andrea Kramer takes a look at news on the Street ahead of the market open

Joseph Hargett takes a look back at news that drove the major market indices today.

Elizabeth Harrow takes a look at news on the Street before the market opens.